nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihomo-gamma-linolenic acid—PTGS2—urinary bladder cancer	0.676	1	CbGaD
Dihomo-gamma-linolenic acid—PTGS2—Cisplatin—urinary bladder cancer	0.101	0.356	CbGbCtD
Dihomo-gamma-linolenic acid—PTGS2—Etoposide—urinary bladder cancer	0.099	0.349	CbGbCtD
Dihomo-gamma-linolenic acid—PTGS1—Etoposide—urinary bladder cancer	0.0836	0.295	CbGbCtD
Dihomo-gamma-linolenic acid—Icosapent—TRPV1—urinary bladder cancer	0.00412	0.343	CrCbGaD
Dihomo-gamma-linolenic acid—Alpha-Linolenic Acid—TRPV1—urinary bladder cancer	0.00403	0.335	CrCbGaD
Dihomo-gamma-linolenic acid—Dinoprostone—HPGDS—urinary bladder cancer	0.00191	0.159	CrCbGaD
Dihomo-gamma-linolenic acid—Icosapent—PPARG—urinary bladder cancer	0.00137	0.114	CrCbGaD
Dihomo-gamma-linolenic acid—FABP7—female reproductive system—urinary bladder cancer	0.00122	0.199	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.00112	0.0505	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—urinary bladder cancer	0.00104	0.0467	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.000889	0.0401	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00076	0.0343	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000603	0.0272	CbGpPWpGaD
Dihomo-gamma-linolenic acid—Icosapent—PTGS2—urinary bladder cancer	0.000578	0.0481	CrCbGaD
Dihomo-gamma-linolenic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000533	0.024	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.000484	0.0218	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.00047	0.0212	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—prostate gland—urinary bladder cancer	0.000444	0.0724	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—prostate gland—urinary bladder cancer	0.000425	0.0692	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000404	0.0183	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—urinary bladder cancer	0.00039	0.0176	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—seminal vesicle—urinary bladder cancer	0.000376	0.0612	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000366	0.0165	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000362	0.0164	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—seminal vesicle—urinary bladder cancer	0.000359	0.0585	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.000356	0.0161	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—GSTO2—urinary bladder cancer	0.000343	0.0155	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—NAT1—urinary bladder cancer	0.000343	0.0155	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000343	0.0155	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—epithelium—urinary bladder cancer	0.000327	0.0532	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000321	0.0145	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000315	0.0512	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000314	0.0142	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—epithelium—urinary bladder cancer	0.000312	0.0508	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.000305	0.0138	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—renal system—urinary bladder cancer	0.000303	0.0493	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000301	0.049	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000296	0.0134	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—renal system—urinary bladder cancer	0.000289	0.0472	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—urethra—urinary bladder cancer	0.000284	0.0463	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000283	0.0128	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000277	0.0125	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.000268	0.0121	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000254	0.0115	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Eicosanoid Synthesis—PTGS2—urinary bladder cancer	0.000253	0.0114	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000245	0.011	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—female reproductive system—urinary bladder cancer	0.000243	0.0395	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000239	0.0108	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000235	0.0106	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—female reproductive system—urinary bladder cancer	0.000232	0.0378	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—vagina—urinary bladder cancer	0.000219	0.0357	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.000212	0.00957	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—vagina—urinary bladder cancer	0.00021	0.0342	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000209	0.00945	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000207	0.00935	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000206	0.00931	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000202	0.0091	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00019	0.00857	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000188	0.0085	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000166	0.00752	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000164	0.00739	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.00016	0.00723	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.00016	0.0072	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000156	0.00706	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000152	0.00687	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.00015	0.00679	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000146	0.00659	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000145	0.00656	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000144	0.0065	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000142	0.00641	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—lymph node—urinary bladder cancer	0.000142	0.0231	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000141	0.00636	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00014	0.00634	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—lymph node—urinary bladder cancer	0.000136	0.0221	CbGeAlD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000131	0.00591	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000131	0.00591	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000127	0.00572	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000121	0.00545	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000113	0.00508	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000111	0.00503	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00011	0.00496	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000109	0.00493	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000109	0.0049	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000108	0.00489	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000104	0.00472	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000104	0.00468	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000101	0.00457	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	9.94e-05	0.00449	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	9.66e-05	0.00436	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	9.3e-05	0.0042	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	9.01e-05	0.00407	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	8.96e-05	0.00404	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	8.85e-05	0.004	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	8.79e-05	0.00397	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.66e-05	0.00391	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.62e-05	0.00389	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.47e-05	0.00382	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	8.07e-05	0.00364	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	8e-05	0.00361	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	7.89e-05	0.00356	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	7.87e-05	0.00355	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	7.55e-05	0.00341	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	6.99e-05	0.00316	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	6.86e-05	0.0031	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	6.84e-05	0.00309	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.8e-05	0.00307	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	6.67e-05	0.00301	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	6.45e-05	0.00291	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	6.21e-05	0.0028	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	6.2e-05	0.0028	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	6.14e-05	0.00277	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.08e-05	0.00275	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.05e-05	0.00273	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—GSTO2—urinary bladder cancer	5.87e-05	0.00265	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—NAT1—urinary bladder cancer	5.87e-05	0.00265	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.78e-05	0.00261	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—GSTO2—urinary bladder cancer	5.57e-05	0.00251	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	5.45e-05	0.00246	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.38e-05	0.00243	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	5.37e-05	0.00243	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.35e-05	0.00242	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	5.35e-05	0.00241	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.33e-05	0.00241	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	5.21e-05	0.00235	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	5.08e-05	0.00229	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	4.94e-05	0.00223	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	4.93e-05	0.00223	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	4.92e-05	0.00222	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	4.84e-05	0.00218	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	4.8e-05	0.00217	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.67e-05	0.00211	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—GSTO2—urinary bladder cancer	4.66e-05	0.00211	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—NAT1—urinary bladder cancer	4.66e-05	0.00211	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.61e-05	0.00208	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.59e-05	0.00207	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	4.57e-05	0.00206	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—PRSS3—urinary bladder cancer	4.45e-05	0.00201	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—SLC19A1—urinary bladder cancer	4.33e-05	0.00195	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	4.27e-05	0.00193	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—PRSS3—urinary bladder cancer	4.22e-05	0.00191	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	4.2e-05	0.0019	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.08e-05	0.00184	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—HDAC4—urinary bladder cancer	4.03e-05	0.00182	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	3.99e-05	0.0018	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.91e-05	0.00177	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	3.84e-05	0.00173	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	3.8e-05	0.00171	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	3.63e-05	0.00164	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.57e-05	0.00161	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—TYMP—urinary bladder cancer	3.56e-05	0.00161	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—PRSS3—urinary bladder cancer	3.53e-05	0.0016	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.46e-05	0.00156	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.42e-05	0.00154	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	3.35e-05	0.00151	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.34e-05	0.00151	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.34e-05	0.00151	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—NAT2—urinary bladder cancer	3.22e-05	0.00145	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—LIG1—urinary bladder cancer	3.2e-05	0.00144	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.18e-05	0.00144	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.09e-05	0.0014	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.83e-05	0.00128	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—TYMP—urinary bladder cancer	2.83e-05	0.00128	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—RRM2—urinary bladder cancer	2.78e-05	0.00125	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.77e-05	0.00125	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.71e-05	0.00123	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.71e-05	0.00122	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.58e-05	0.00117	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—ENO2—urinary bladder cancer	2.57e-05	0.00116	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—HPGDS—urinary bladder cancer	2.57e-05	0.00116	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.56e-05	0.00116	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.56e-05	0.00115	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.56e-05	0.00115	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—GSTT1—urinary bladder cancer	2.5e-05	0.00113	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.46e-05	0.00111	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—ENO2—urinary bladder cancer	2.44e-05	0.0011	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—RBX1—urinary bladder cancer	2.31e-05	0.00104	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.28e-05	0.00103	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.21e-05	0.000996	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.07e-05	0.000936	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—JAG1—urinary bladder cancer	2.07e-05	0.000934	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.04e-05	0.000922	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.04e-05	0.000922	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.03e-05	0.000917	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.01e-05	0.000908	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—GSTT1—urinary bladder cancer	1.98e-05	0.000894	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.95e-05	0.000881	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.75e-05	0.000792	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.73e-05	0.000781	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.67e-05	0.000756	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.65e-05	0.000743	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.61e-05	0.000726	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.59e-05	0.000718	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.59e-05	0.000718	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.52e-05	0.000687	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—NCOR1—urinary bladder cancer	1.51e-05	0.00068	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.49e-05	0.000675	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—ERCC2—urinary bladder cancer	1.42e-05	0.00064	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.4e-05	0.000634	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.39e-05	0.000629	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.37e-05	0.00062	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—MTHFR—urinary bladder cancer	1.33e-05	0.000601	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.33e-05	0.0006	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—TERT—urinary bladder cancer	1.33e-05	0.0006	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.28e-05	0.000576	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.26e-05	0.00057	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.26e-05	0.00057	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—FGFR3—urinary bladder cancer	1.22e-05	0.00055	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.21e-05	0.000546	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.19e-05	0.000536	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.14e-05	0.000514	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.12e-05	0.000504	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.09e-05	0.000494	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—CREBBP—urinary bladder cancer	1.04e-05	0.000468	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—RHOA—urinary bladder cancer	9.38e-06	0.000424	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—PPARG—urinary bladder cancer	9.04e-06	0.000408	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—PTGS2—urinary bladder cancer	8.96e-06	0.000405	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—CREBBP—urinary bladder cancer	8.69e-06	0.000392	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—ERBB2—urinary bladder cancer	8.69e-06	0.000392	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—PTEN—urinary bladder cancer	7.82e-06	0.000353	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS1—Metabolism—EP300—urinary bladder cancer	7.45e-06	0.000336	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—CDKN1A—urinary bladder cancer	7.43e-06	0.000335	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—PTEN—urinary bladder cancer	7.41e-06	0.000334	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—EP300—urinary bladder cancer	7.07e-06	0.000319	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—SRC—urinary bladder cancer	6.87e-06	0.00031	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—PTEN—urinary bladder cancer	6.2e-06	0.00028	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—MYC—urinary bladder cancer	6.16e-06	0.000278	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—EGFR—urinary bladder cancer	6.02e-06	0.000272	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Metabolism—EP300—urinary bladder cancer	5.92e-06	0.000267	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—KRAS—urinary bladder cancer	5.69e-06	0.000257	CbGpPWpGaD
Dihomo-gamma-linolenic acid—PTGS2—Disease—HRAS—urinary bladder cancer	4.84e-06	0.000218	CbGpPWpGaD
